Logiciel board meets May 29 to consider FY26 results
Logiciel Solutions Limited will hold a board meeting on May 29, 2026, to approve audited financial results for the year ended March 31, 2026. The meeting will also cover audited financial statements and regulatory compliance statements. The trading window for designated persons remains closed until May 31, 2026.

*this image is generated using AI for illustrative purposes only.
Logiciel Solutions Limited has scheduled a board meeting for Friday, May 29, 2026, to consider and approve the audited financial results for the half-year and financial year ended March 31, 2026. The meeting will be held pursuant to Regulation 29 of the SEBI LODR Regulations.
Agenda for the Meeting
The board will deliberate on several key items, including the audited financial results along with the Auditor's Report. The directors will also consider the audited financial statements of the company for the financial year ended March 31, 2026. Furthermore, the board will review the Statement of Deviation or Variation as required under Regulation 32 of SEBI LODR and discuss any other matter with the permission of the Chair.
Trading Window Closure
In continuation of an earlier intimation dated March 27, 2026, the company has informed that the trading window for dealing in securities remains closed. This restriction applies to all designated persons and their immediate relatives. The window will reopen 48 hours after the declaration of the audited financial results, which is effective until May 31, 2026.
Key Meeting Details
| Detail | Information |
|---|---|
| Meeting Date | May 29, 2026 |
| Financial Year End | March 31, 2026 |
| Purpose | Audited Results & Statements |
| Trading Window Reopens | May 31, 2026 |
Historical Stock Returns for Logiciel Solutions
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.47% | -2.26% | -15.54% | -69.66% | -71.17% | -71.17% |
How might Logiciel Solutions Limited's audited financial results for FY2026 compare to its previous year's performance, and what growth trajectory could investors expect?
Will the board meeting on May 29 include any announcements regarding dividends, fundraising, or strategic expansions that could impact the stock price post-trading window reopening?
Are there any potential red flags in the Statement of Deviation or Variation under Regulation 32 that could signal misuse of funds raised from investors?



























